HOME >> BIOLOGY >> NEWS
Distinguishing friend from foe in the battle against cancer

The latest generation of cancer chemotherapeutic drugs specifically targets mutant enzymes or "oncoproteins" that have run amok and now promote uncontrolled cell growth. As promising as these drugs are, cancer cells with their backs against the wall have the tendency to fight back. A major goal of cancer research is to frustrate these acts of cellular desperation.

In a forthcoming issue of Cancer Cell, investigators at the Salk Institute for Biological Studies uncover one means cancer cells use to stay alive and in doing so suggest a strategy to overcome their recalcitrance. The study, led by Tony Hunter, Ph.D., in collaboration with Inder Verma, Ph.D., shows that resistance to the chemotherapeutic drug rapamycin is mediated by the survival factor NF-kB.

Rapamycin, like the pharmaceutical superstar Gleevec, which revolutionized the treatment of chronic myelogenous leukemia, is a so-called signal transduction inhibitor or STI, a small molecule that stifles inappropriate growth signals sent by mutant proteins in cancer cells. STIs may look like overnight successes, but they are actually the result of decades of hard work.

"We have been working for 35 years looking at mechanisms underlying formation of cancer cells," says Hunter, an American Cancer Society professor in the Molecular and Cell Biology Laboratory. "We've made huge progress identifying specific events that change normal proteins into proteins that cause cancer and developing drugs that target those proteins. This work provides another potential direct target for development of cancer drugs."

The Hunter lab previously showed that mouse cells lacking tumor suppressors known as TSC genes are more susceptible to the lethal effects of chemotherapeutic agents than are normal cells. Why cells from these TSC null mice were so poorly equipped to survive was not entirely clear.

Co-lead authors Sourav Ghosh, Ph.D., and Vinay Tergaonkar, Ph.D., postdoctoral fellows in
'"/>

Contact: Gina Kirchweger
Kirchweger@salk.edu
858-453-4100 x1340
Salk Institute
11-Sep-2006


Page: 1 2 3

Related biology news :

1. A friendly foe -- Bacteria residing in the gut boost immune response to tumors
2. When the villain becomes your friend: The strange tale of muscle lactate
3. FSU pushing boundaries with environmentally friendly community
4. Mans best friend lends insight into human evolution
5. To trust or not to trust your friends
6. Train your brain to hear your friends at a party
7. New Queens study offers environmentally friendly solution to oil industry needs
8. Rewiring the mammalian brain -- neurons make fickle friends
9. HO-1 in sickle cell disease: friend or foe?
10. Eco-friendly bug sucker
11. Surprising symbiosis: Glassy-winged sharpshooter eats with friends

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/14/2019)... ... August 14, 2019 , ... Gateway Genomics , a leading ... inclusion in the 38th annual Inc. 500|5000 list of fastest growing private ... companies must have been founded and generating revenue by March 31, 2015. Ranking in ...
(Date:8/14/2019)... ... ... Julie Reck of Veterinary Medical Center of Fort Mill has recently begun providing ... her own geriatric Australian Shepherd, Simon, was treated in June 2019 for osteoarthritis in his ... body was weak, and he struggled to play fetch and other games with his family. ...
(Date:8/6/2019)... ... August 06, 2019 , ... A study released today in ... far-reaching implications for personalized medicine, especially when seeking treatments for children with heart ... which stem cell donors and manipulation methods might yield the best therapies for ...
Breaking Biology News(10 mins):
(Date:9/11/2019)... ... 2019 , ... An upcoming episode of Advancements with Ted ... sequencing analysis. Check your local listings for more information. , Advancements will go ... and will explore its revolutionary pathogenic DNA analysis technology, which predicts in real-time, ...
(Date:9/8/2019)... , ... September 05, 2019 , ... ... Blaine Fitzgerald, former Vice President of Finance for Shopify, has been named Chief ... and healthcare venture capitalist Joel Finlayson as strategic advisors. Additionally, Spartan has hired ...
(Date:8/29/2019)... ... August 28, 2019 , ... ... Danisco® ingredient solutions to attendees at the International Baking Industry Expo, September 8 ... challenges from optimizing production efficiency to cost and waste reduction and from maintaining ...
(Date:8/25/2019)... ... 2019 , ... Authors Gopal Nayak and Mahendra Kumar Trivedi ... “Impact of Biofield Treatment on Growth and Anatomical Characteristics of Pogostemon cablin (Benth.)" ... book garnered No. 1 status on Amazon in several categories including: Mind-Body Medicine, ...
Breaking Biology Technology:
Cached News: